Pulmonology Medical News about Pulmonary Disease, Chronic Obstructive

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Parasternal muscle activity decreases in severe COPD with salmeterol-fluticasone propionate
Chest, 10/20/09

Easton PA et al. – In severe COPD, with very minimal change in hyperinflation or pulmonary mechanics, salmeterol–fluticasone induced a very significant decrease in activity of the chest wall parasternal inspiratory muscle. This may be of practical benefit to reverse the extensive use of the chest wall muscles and alleviate dyspnea in severe COPD.

<< Previous
ARDS of early or late onset: Does it make a difference

Next >>
A phase II study of amrubicin combined with carboplatin for...